The Latest Research and Treatment for Adult Brain Tumors

David Reardon, Patrick Wen, brain tumors

Patrick Wen, MD, and David Reardon, MD

Historically, brain tumors have been some of the most challenging types of cancers. A protective barrier around the brain—called the “blood-brain barrier”—can prevent cancer treatments from reaching the tumor. Recently, increased interest in immunotherapy has given new hope to getting through this barrier.

“We know the immune system can get into the brain to fight infections and inflammatory conditions,” says David Reardon, MD, clinical director of Dana-Farber’s Center for Neuro-Oncology. “Our current research is moving forward to a level where we’re critically confirming that these immunotherapy drugs are getting into the brain and making a difference.”

Reardon recently joined Patrick Wen, MD, director of Dana-Farber’s Center for Neuro-Oncology, for a live video webchat on the latest research and treatments for adult brain tumors. During the chat, Reardon and Wen discussed a number of new treatment options currently being researched for patients, including advancements in genomics and precision medicine.

“One major area of advancement in all cancer, including brain tumors, is the understanding of the molecular changes that drive tumors,” says Wen. “We’ve been able to characterize molecular changes in both high-grade and low-grade gliomas, and because of that we can develop drugs to target the molecular drivers of these tumors.”

Combining these two new areas of research, Reardon says, is also showing promise for the future.

“With immunotherapies, we know some cancers respond and others don’t, and some patients respond while others don’t, and we need to figure out why that is,” Reardon adds. “If we can understand what’s unique and different about the patient’s immune status as well as their tumor profile, we can find the right immunotherapy for that patient.”

Watch the webchat video below to learn more about these new treatments and other research advances for adult brain tumors:

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Basic, Clinical and Translational Research: What’s the Difference? https://t.co/y42sqY2lZk #research https://t.co/uwgS13YdDq
Dana-Farber @danafarber
RT @ASH_hematology: ASH thanks 2017 President Kenneth Anderson, MD, of @DanaFarber for his leadership and service to the Society #ASH17 htt…
Dana-Farber @danafarber
Congratulations to Dana-Farber/@BrighamWomens’ Dr. Benjamin Ebert, recipient of the William Dameshek Prize, awarded… https://t.co/cG7FjvRBHC

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.